BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.12 USD | +2.17% |
|
-0.28% | -19.85% |
| 06-02 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
| 06-02 | GSK blood cancer drug nearly halves risk of death in late-stage trial | RE |
Official Publications
| SEC Filing 8K | CO | |
| SEC Filing 10Q-1 | CO | |
| Slide show Q1 | CO | |
| 1st quarter results | CO | |
| SEC Filing 8K | CO | |
| Proxy Statments | CO | |
| SEC Filing 4K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 10K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 8K | CO | |
| Dividends | CO | |
| SEC Filing 10Q-3 | CO | |
| Slide show Q3 | CO | |
| 3rd quarter results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 4K | CO | |
| SEC Filing 8K | CO | |
| Slide show half-year results | CO | |
| 1st-half-year results | CO | |
| SEC Filing 10Q-2 | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 4K | CO |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Official Publications
